Diabetes Mellitus, Type 2 Clinical Trial
— DATSOfficial title:
Effects of Two Models of Physical Training in Aquatic Environment in Control of Type 2 Diabetes - A Controled Randomized Clinical Trial: The Diabetes and Aquatic Training Study (DATS)
This study evaluates the effects of the combined exercise training (aerobic more resistance) and of the aerobic exercise training isolated compared to control group, which performed only stretching and relaxation, in the treatment of type 2 diabetes (T2DM). The two exercise interventions and the control procedure are performed in aquatic environment.
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | May 2016 |
| Est. primary completion date | December 2015 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 30 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - Type 2 diabetes; - Be under medical treatment with oral hypoglycemic agents and / or insulin; - Not engaged in regular exercise (regular exercise was defined as performing any type of physical training for at least 20 minutes three or more days a week). Exclusion Criteria: - Severe autonomic neuropathy; - Severe nonproliferative and proliferative diabetic retinopathy; - Decompensated heart failure; - Limb amputations; - Severe foot injuries; - Chronic renal failure (Modification Diet in Renal Disease-MDRD, Glomerular Filtration Rate-GFR < 30 ml/min); - Body mass index (BMI) > 45.0 kg/m2; - Any muscle or joint impairment which prevented individuals from engaging in physical exercise. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Hospital de Clinicas de Porto Alegre |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes in levels of glycated hemoglobin | Change from Baseline levels of glycated hemoglobin at 15-weeks. | No | |
| Secondary | Fasting plasma glucose. | At baseline and after a 15-week period. | No | |
| Secondary | Fasting insulin. | At baseline and after a 15-week period. | No | |
| Secondary | Insulin-resistance index (HOMA-IR). | At baseline and after a 15-week period. | No | |
| Secondary | Total cholesterol. | At baseline and after a 15-week period. | No | |
| Secondary | high density lipoprotein. | At baseline and after a 15-week period. | No | |
| Secondary | Low density lipoprotein. | At baseline and after a 15-week period. | No | |
| Secondary | Triglycerides. | At baseline and after a 15-week period. | No | |
| Secondary | Renin | At baseline and after a 15-week period. | No | |
| Secondary | High sensitive C-reactive protein. | At baseline and after a 15-week period. | No | |
| Secondary | Total testosterone. | At baseline and after a 15-week period. | No | |
| Secondary | Cortisol | At baseline and after a 15-week period. | No | |
| Secondary | Testosterone/cortisol ratio. | At baseline and after a 15-week period. | No | |
| Secondary | Peak oxygen uptake. | At baseline and after a 15-week period. | No | |
| Secondary | Oxygen uptake at the second ventilatory threshold. | At baseline and after a 15-week period. | No | |
| Secondary | Percentage of oxygen consumption in the second ventilatory threshold from the peak oxygen uptake. | At baseline and after a 15-week period. | No | |
| Secondary | Systolic blood pressure. | At baseline and after a 15-week period. | No | |
| Secondary | Diastolic blood pressure | At baseline and after a 15-week period. | No | |
| Secondary | Heart rate at rest. | At baseline and after a 15-week period. | No | |
| Secondary | Maximum dynamic muscle strength (1RM) in the knees extension exercise. | The test is characterized by greater load that can be supported in a single execution of knees extension exercise. | At baseline and after a 15-week period. | No |
| Secondary | Maximum dynamic muscle strength (1RM) in the elbows flexion exercise. | The test is characterized by greater load that can be supported in a single execution of elbows flexion exercise. | At baseline and after a 15-week period. | No |
| Secondary | Resistant dynamic muscle strength (maximal repetitions) in the knees extension exercise. | To determine the resistant dynamic muscle strength, it was considered the number of repetitions performed at 60% of 1RM, following a pace and breadth of pre-established execution. In the post-training evaluation, we used the load of 60% of 1RM test performed in the pre-training. | At baseline and after a 15-week period. | No |
| Secondary | Resistant dynamic muscle strength (maximal repetitions) in the elbows flexion exercise. | To determine the resistant dynamic muscle strength, it was considered the number of repetitions performed at 60% of 1RM, following a pace and breadth of pre-established execution. In the post-training evaluation, we used the load of 60% of 1RM test performed in the pre-training. | At baseline and after a 15-week period. | No |
| Secondary | Timed up and go test performed at the usual speed. | At baseline and after a 15-week period. | No | |
| Secondary | Timed up and go test performed at the maximal speed. | At baseline and after a 15-week period. | No | |
| Secondary | Sitting-rising test (SRT). | The SRT basically consists in the quantification of the number of support (hands and/or knees, or hands or forearms on knees) one utilizes in order to sit and to rise from the floor. | At baseline and after a 15-week period. | No |
| Secondary | Overall quality of life and in physical, psychological, social relationships and environment domains, evaluated by instrument of World Health Organization (WHOQOL). | To evaluate the quality of life we used the WHOQOL-brief instrument. This instrument is self-applicable, cross-cultural, translated and validated for Portuguese, consisting of 26 questions. Its score ranges from zero to 100 points, divided into the physical, psychological, social relationships and environment, as well as an assessment of the overall quality of life. | At baseline and after a 15-week period. | No |
| Secondary | Depressive symptoms, evaluated by Depression Inventory Patient Health Questionnarie (PHQ-9) | For evaluation of depressive symptoms was used the questionnaire PHQ-9 depression, which consists of nine items, including symptoms and attitudes whose intensity varies from zero to three, with 27 your score. | At baseline and after a 15-week period. | No |
| Secondary | Sleep quality, evaluated by Pittsburgh Sleep Scale | Sleep quality was assessed by Pittsburgh scale, consisting of 19 questions on the perception of oneself and five questions relating to the perception that the roommates of these individuals have about sleep the same. These questions are grouped into seven components, with score of zero to three. | At baseline and after a 15-week period. | No |
| Secondary | Levels of sleep Obstructive Apnea, evaluated by Berlin Questionnaire (BQ) | This questionnaire includes 10 items, organized in 3 categories related to snoring and apneas witnessed (5 items), daytime sleepiness (4 items) and high blood pressure (HTA) / obesity (1 item). Information on gender, age, height, weight, race neck circumference and is also requested. The determination of high or low risk to OSAS is based on responses in each category itens. | At baseline and after a 15-week period. | No |
| Secondary | Physical activity levels, evaluated by International Physical Activity Questionnaire (IPAQ) - Short Form. | The IPAQ short form asks about three specific types of activity undertaken in the three domains introduced above and sitting. The specific types of activity that are assessed are walking, moderate-intensity activities and vigorous intensity activities; frequency (measured in days per week) and duration (time per day) are collected separately for each specific type of activity. | At baseline and after a 15-week period. | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |